NEW YORK , April 30, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ: ALDX). Such investors...
NEW YORK , April 30, 2026 /PRNewswire/ --
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their Options
Important Information Regarding Section 20(a) Individual Liability Claims
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November...
Disclosure Under Scrutiny: Were Risk Warnings About Reproxalap Adequate?
The Red Flags: What Insiders Allegedly Knew Before Shareholders Did
NEW YORK , April 27, 2026 /PRNewswire/ --
Key Dates and Disclosure Events Shareholders Need to Know
If you have suffered a loss on your Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ:ALDX) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at...